CN Patent

CN110996953A — 用心脏肌小节激活剂治疗心力衰竭的方法

Assigned to Amgen Inc · Expires 2020-04-10 · 6y expired

What this patent protects

本文提供了治疗患有心力衰竭的受试者的方法，这些方法包括向该受试者施用初始剂量的心脏肌小节激活剂(CSA)持续初始时间段，以及随后基于在该初始时间段结束时的该受试者的CSA血药浓度向该受试者施用一定剂量的该CSA。

USPTO Abstract

本文提供了治疗患有心力衰竭的受试者的方法，这些方法包括向该受试者施用初始剂量的心脏肌小节激活剂(CSA)持续初始时间段，以及随后基于在该初始时间段结束时的该受试者的CSA血药浓度向该受试者施用一定剂量的该CSA。

Drugs covered by this patent

Patent Metadata

Patent number
CN110996953A
Jurisdiction
CN
Classification
—
Expires
2020-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Amgen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.